A first-in-human proof-of-concept trial of intravaginal artesunate to treat cervical intraepithelial neoplasia 2/3 (CIN2/3). [electronic resource]
Producer: 20201006Description: 188-194 p. digitalISSN:- 1095-6859
- Administration, Intravaginal
- Adult
- Antineoplastic Agents -- administration & dosage
- Artesunate -- administration & dosage
- Dose-Response Relationship, Drug
- Female
- Humans
- Papillomaviridae -- isolation & purification
- Papillomavirus Infections -- drug therapy
- Proof of Concept Study
- Self Administration
- Uterine Cervical Neoplasms -- drug therapy
- Uterine Cervical Dysplasia -- drug therapy
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.